Phase 1b/2 Study of Carfilzomib, Pomalidomide, and Dexamethasone (KPd) in Patients (Pts) with Lenalidomide-Exposed and/or -Refractory but Proteasome Inhibitor (PI)-Naive or -Sensitive Multiple Myeloma: A Multiple Myeloma Research Consortium Multi-Center Study - Rosenbaum, Cara A.; Kukreti, Vishal; Zonder, Jeffrey; Lebovic, Daniel; Zimmerman, Todd; Berdeja, Jesus G.; McDonnell, Kathryn; Waite-Marin, Jessica; Griffith, Kent A.; Jakubowiak, Andrzej (Blood, 2014)